v3.25.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Successor
Common Stock
Predecessor
Preferred Stock
Series A
Successor
Additional 
Paid-In 
Capital
Successor
Additional 
Paid-In 
Capital
Predecessor
Accumulated Deficit
Successor
Accumulated Deficit
Predecessor
Accumulated 
Other 
Comprehensive 
Loss
Successor
Accumulated 
Other 
Comprehensive 
Loss
Predecessor
Treasury Stock
Predecessor
Successor
Predecessor
Balances at Dec. 31, 2021   $ 50     $ 508,525   $ 3,693   $ 13,188 $ (276)   $ 525,180
Balances (in Shares) at Dec. 31, 2021   5,027,825                    
Net income (loss)         20,043     20,043
Exercise of stock options       66       66
Exercise of stock options (in Shares)   659                    
Share-based compensation expense       2,561       2,561
Capital contributions from stockholder       200       200
Capital contributions from stockholder (in Shares)   1,331                    
Treasury stock repurchased           (753)   (753)
Treasury stock repurchased (in Shares)   (5,013)                    
Other comprehensive income (loss)           (25,168)   (25,168)
Balances at Dec. 31, 2022   $ 50     511,352   23,736   (11,980) (1,029)   522,129
Balances (in Shares) at Dec. 31, 2022   5,024,802                    
Net income (loss)         (6,289)     (6,289)
Dividend       (150,000)       (150,000)
Share-based compensation expense       4,975       4,975
Other comprehensive income (loss)           11,184   11,184
Balances at Dec. 31, 2023   $ 50     366,327   17,447   (796) (1,029)   381,999
Balances (in Shares) at Dec. 31, 2023   5,024,802                    
Net income (loss)         (1,271)     (1,271)
Share-based compensation expense       897       897
Other comprehensive income (loss)           (9,578)   (9,578)
Balances at Mar. 31, 2024   $ 50     367,224   16,176   (10,374) (1,029)   372,047
Balances (in Shares) at Mar. 31, 2024   5,024,802                    
Balances at Dec. 31, 2023   $ 50     366,327   17,447   (796) (1,029)   381,999
Balances (in Shares) at Dec. 31, 2023   5,024,802                    
Net income (loss)         (15,703)     (15,703)
Share-based compensation expense       17,858       17,858
Other comprehensive income (loss)           (18,004)   (18,004)
Balances at Jul. 29, 2024 $ 50 $ 557,427 384,185 $ (1,537) 1,744 (18,800) (1,029) $ 555,890 366,150
Balances (in Shares) at Jul. 29, 2024 53,975,000 5,024,802 1,000,000                  
Balances at Dec. 31, 2023   $ 50     366,327   17,447   (796) (1,029)   381,999
Balances (in Shares) at Dec. 31, 2023   5,024,802                    
Balances at Dec. 31, 2024 $ 12   1,293,638   (106,989)   (35,489)     1,151,172  
Balances (in Shares) at Dec. 31, 2024 121,476,215   1,000,000                  
Balances at Jul. 29, 2024 $ 50 557,427 $ 384,185 (1,537) $ 1,744 $ (18,800) $ (1,029) 555,890 $ 366,150
Balances (in Shares) at Jul. 29, 2024 53,975,000 5,024,802 1,000,000                  
Net income (loss)     (105,452)       (105,452)  
Share-based compensation expense   64,626         64,626  
Settlement of derivative liability   967         967  
Equity consideration issued in conjunction with Acuren Acquisition   4,000         4,000  
Equity consideration issued in conjunction with Acuren Acquisition (in Shares) 400,000                      
Issuance of common shares and exercise of warrants, net of issuance costs   666,630         666,630  
Issuance of common shares and exercise of warrants, net of issuance costs (in Shares) 67,037,515                      
Issuance of common shares to employees            
Issuance of common shares to employees (in Shares) 63,700                      
Impact of Domestication $ 12   (12)          
Other comprehensive income (loss)       (35,489)     (35,489)  
Balances at Dec. 31, 2024 $ 12   1,293,638   (106,989)   (35,489)     1,151,172  
Balances (in Shares) at Dec. 31, 2024 121,476,215   1,000,000                  
Net income (loss)     (25,793)       (25,793)  
Share-based compensation expense   1,107         1,107  
Other comprehensive income (loss)       2,561     2,561  
Balances at Mar. 31, 2025 $ 12   $ 1,294,745   $ (132,782)   $ (32,928)     $ 1,129,047  
Balances (in Shares) at Mar. 31, 2025 121,476,215   1,000,000